Cannovum AG Establishes Cultivation Alliance For Germany
PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany.
PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany.
PRESS RELEASE FOR the first time, cannabis is being sold legally in Switzerland.
PRESS RELEASE THE Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors.
PRESS RELEASE 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced the acquisition of privately held RX Pharmatech Ltd (RXP), a leading United Kingdom distributor of cannabinoids with 1,276 novel food applications with the U.K.
PRESSEMITTEILUNG Die Kernstrategie von Hellenic Dynamics besteht darin, seine 40.000 Quadratmeter große Lizenz für den aktiven THC-Anbau in seiner 195.506 Quadratmeter großen Anlage in der Nähe von Thessaloniki in Nordgriechenland zu entwickeln und zu betreiben.
PRESS RELEASE Hellenic Dynamics’ core strategy is to develop and operate its 40,000 square metre active THC cultivation licence from its 195,506 square metre facility located near Thessaloniki in Northern Greece.
PRESS RELEASE Key NHS cannabis project to kick off A key project developing a flexible health economics analysis tool to evaluate the potential of cannabis prescriptions on the NHS is set to kick off, after funding was secured from a range of backers.
Chris Allen, Executive Director of Hemp Federation Ireland, elaborates on the Irish authorities’ legal turmoil over hemp and CBD.
PRESS RELEASE KHIRON Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), continues to spearhead the medical cannabis market in the United Kingdom by successfully attaining, for the first time, full reimbursement by the NHS of costs associated to cannabis-based medication and clinic fees for a patient enrolled in Zerenia™ Clinics UK.